Or. Admin. Code § 333-333-2120

Current through Register Vol. 63, No. 11, November 1, 2024

Section 333-333-2120 - Psilocybin Product Delivery Methods

(1) A manufacturer must design and manufacture all psilocybin products to be consumed by a client orally or delivered via another enteral method

(2) A manufacturer is prohibited from designing or manufacturing psilocybin products that can be delivered to clients through any method other than orally or another enteral method. A manufacturer is prohibited from designing or manufacturing psilocybin products that include but not limited to, transdermal patches, inhalers, nasal sprays, suppositories and injections.

PH 74-2022, adopt filed 05/19/2022, effective 5/20/2022

Statutory/Other Authority: ORS 475A.235

Statutes/Other Implemented: ORS 475A.235